Skip to main content

Table 1 Patient characteristics and outcomes

From: Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008

Characteristics All patients (n = 90) 5% of all breast cancers (n = 1800) Patients with nonmetastatic disease (n = 72)
Patient’s characteristics   
Age   
  Median 47 47
  Range 29 - 75 29 - 75
Menoposal status   
  Premenoposal 51 (56.7%) 38 (53%)
  Postmenoposal 34 (37.8%) 30
  Unknown 5 4
Histilogy   
  Infiltrating ductal carcinoma 84 (93.3%) 69 (96%)
  Infiltrating lobular carcinoma 3 (3.3%) 2
  Other 3 (3.3%) 3
SBR   
  I 5 (5.6%) 4
  II 45 (50%) 36
  III 24 (26.7%) 20
  Unknown 16 (17.7%) 12
Hormone receptor status   
  ER+/PR+ 37 30
  ER+/PR- 0 0
  ER-/PR+ 23 19 (26.4%)
  ER-/PR- 4 4 (5.6%)
  Unknown 26 19
HER2/neu status   
  Positif 23 (25.5%) 18 (25%)
  Negatif 22 20
  Unknown 45 34
Clinical stage N   
  N0 31 (34.4%) 23 (32%)
  N1 42 (46.7%) 33
  N2 12 (13.3%) 12
  N3 5 (5.6%) 4
Clinical stage M   
  M0 72 (80%) 72
  M1 18 (20%) 0
Taxanes   
  Yes 45 37 (51.4%)
  No 43 35 (48.6%)
  Unknown 2 0
Surgery   
  Yes 53 51 (71%)
  No 37 21 (29%)
Radiotherapy   
  Yes 40 39 (54%)
  No 50 33 (36%)
  cOR (CR + PR) - 49 (68%)
  pCR - 1 (1.4%)
  Pathologically negative lymph nodes   5 (7%)
  1 and 2 y LRRFS - 90.8%; 78.1%
  1 and 2 y EFS - 81.7%; 57.5%
  1 and 2 y OS - 94.3%; 74.6%